X0206 3 2017-11-16 0 0001604950 scPharmaceuticals Inc. SCPH 0001722234 Agger Mette Kirstine C/O SCPHARMACEUTICALS INC. 2400 DISTRICT AVENUE, SUITE 310 BURLINGTON MA 01830 1 0 0 0 Series A Preferred Stock Common Stock 11092383 I By: Lundbeckfond Invest A/S Series B Preferred Stock Common Stock 7067945 I By: Lundbeckfond Invest A/S All series of Convertible Preferred Stock will automatically convert into scPharmaceuticals Inc. common stock on a 7.180193-for-1 basis immediately prior to the closing of the initial public offering and have no expiration date. These shares are directly held by Lundbeckfond Invest A/S. The Reporting Person is the Managing Partner at Lundbeckfonden Ventures, which is the General Partner of Lundbeckfond Invest A/S. The reporting person disclaims beneficial ownership of such shares except to the extent of her pecuniary interest, if any, and this report shall not be deemed an admission that the reporting person is the beneficial owner of all of the reported shares for purposes of Section 16 or any other purpose. Exhibit 24 - Power of Attorney /s/ Courtney Gaughan, Attorney-in-Fact 2017-11-16